These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7477992)

  • 1. Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy.
    Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
    Neurology; 1995 Oct; 45(10):1914-8. PubMed ID: 7477992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum levels of soluble E- and L-selectin in patients with human T-cell lymphotropic virus type I-associated myelopathy.
    Tsujino A; Nakamura T; Furuya T; Goto H; Nishiura Y; Shirabe S; Nakane S; Motomura M; Nagataki S
    J Neurol Sci; 1998 Feb; 155(1):76-9. PubMed ID: 9562326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis.
    McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
    J Neuroimmunol; 1998 May; 85(2):186-92. PubMed ID: 9630167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
    Kuenz B; Lutterotti A; Khalil M; Ehling R; Gneiss C; Deisenhammer F; Reindl M; Berger T
    J Neuroimmunol; 2005 Oct; 167(1-2):143-9. PubMed ID: 16040131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity.
    Dore-Duffy P; Newman W; Balabanov R; Lisak RP; Mainolfi E; Rothlein R; Peterson M
    Ann Neurol; 1995 Jan; 37(1):55-62. PubMed ID: 7529475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombomodulin in the sera of patients with multiple sclerosis and human lymphotropic virus type-1-associated myelopathy.
    Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1995 Jan; 56(1):113-6. PubMed ID: 7822477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
    Inoue A; Koh CS; Sakai T; Yamazaki M; Yanagisawa N; Usuku K; Osame M
    J Neuroimmunol; 1997 May; 75(1-2):141-6. PubMed ID: 9143247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
    Witkowska AM; Socha K; Kochanowicz J; Karpińska E; Jakoniuk M; Zujko ME; Wilkiel M; Borawska MH; Mariak Z
    Biol Res Nurs; 2016 Jan; 18(1):113-9. PubMed ID: 25911236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Ohta M; Ohta K; Nishimura M; Saida T
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):603-5. PubMed ID: 12564844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy.
    Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1995 Jun; 59(1-2):35-40. PubMed ID: 7541057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
    Mitosek-Szewczyk K; Stelmasiak Z; Bartosik-Psujek H; Belniak E
    Acta Neurol Scand; 2010 Dec; 122(6):409-13. PubMed ID: 20175758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
    Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
    Ann Neurol; 1993 Jun; 33(6):646-9. PubMed ID: 8098933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble L-selectin levels in serum and cerebrospinal fluid in patients with multiple sclerosis and systemic lupus erythematosus.
    Baraczka K; Pozsonyi T; Nékám K; Virányi M; Seszták M; Szongoth M; Jakab L
    Acta Neurol Scand; 2000 Aug; 102(2):114-7. PubMed ID: 10949528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of soluble adhesion molecules in sera and BAL fluid of individuals infected with human T-cell lymphotropic virus type 1.
    Seki M; Higashiyama Y; Kadota J; Mukae H; Yanagihara K; Tomono K; Kohno S
    Chest; 2000 Dec; 118(6):1754-61. PubMed ID: 11115469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of soluble form of selectin family in the sera of patients with neuroimmunological disorders].
    Sakai T; Inoue A; Koh CS; Yamazaki M; Yanagisawa N
    Rinsho Shinkeigaku; 1998 Mar; 38(3):197-202. PubMed ID: 9711113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy.
    Hayashi D; Kubota R; Takenouchi N; Nakamura T; Umehara F; Arimura K; Izumo S; Osame M
    J Neurovirol; 2008 Oct; 14(5):459-63. PubMed ID: 18989817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis.
    McMillan SA; McDonnell GV; Douglas JP; Hawkins SA
    Acta Neurol Scand; 2000 Apr; 101(4):239-43. PubMed ID: 10770519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease.
    Giovannoni G; Thorpe JW; Kidd D; Kendall BE; Moseley IF; Thompson AJ; Keir G; Miller DH; Feldmann M; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):20-6. PubMed ID: 8558145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
    Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
    Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement.
    Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M
    Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.